Initial Molecular Response at 3 Months May Predict Both Response and Event-Free Survival at 24 Months in Imatinib-Resistant or -Intolerant Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase Treated With Nilotinib - Branford, Susan; Müller, Martin Christian (Journal of clinical oncology, 2012)
Published online ahead of print at www.jco.org on October 29, 2012